Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
America, antagonist, APP, assemble, Astra, bear, benign, bring, Bristol, call, Canada, carefully, Carlsbad, chemotherapy, Cipro, cisplatin, Commissioner, Committee, consent, defray, degree, delivery, developmental, Diflucan, disposition, distributor, dominated, effort, enable, encounter, Eon, erosion, exacerbate, exemption, exploit, feature, fill, formulation, full, Gedeon, Genentech, Genpharm, GnRH, Gonadotropin, hormone, hurt, hypertrophy, imprudent, IVAX, Japan, LHRH, Luteinizing, maintenance, Mayne, Medicare, met, Mexico, Modernization, modest, Mylan, newly, nomination, North, notable, Novopharm, open, outcome, Paraplatin, Park, partially, passage, pediatric, Pharmachemie, pharmacy, Pliva, precision, prescription, prevalent, printing, program, proliferative, Ranbaxy, readily, ready, recover, Reddy, refractory, refrain, reimbursement, remote, rest, Richter, Roche, Roxane, Sandoz, specific, supplier, tablet, Taro, Technilab, tentative, thirteen, tied, twelve, upfront, viability, Ward, West, written, Zeneca
Filing tables
Filing exhibits
Related press release
SPPI similar filings
External links